ArticleVaccines2022

CCL28 Enhances HSV-2 gB-Specific Th1-Polarized Immune Responses against Lethal Vaginal Challenge in Mice.

Yan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.